Maelstrom Research Staging | CAMICCov_Immunosuppressed

CAMICCov_Immunosuppressed_Enrollment

Networks -

Variables -

Associated study CAMICCov Contingency Table

Population

CAMICCov - Immunosuppressed

The population is composed of adult and stable kidney recipients who are participants in the TCAD study (Two-step Cell-based Assay to Diagnose over-immunosuppression).

Selection Criteria

Newborns

Twins

Countries

Canada

Territory

Ethnic Origin

Health Status

Participants are included if they are stable kidney recipients.

Other Criteria

Supplementary Information about selection criteria

Recruitment

Sources of recruitment

Participants from existing studies

Supplementary Information

Participants enrolled in this study are among the TCAD cohort enrolled in the Quebec city area.

Participants from Existing Studies

TCAD

Number of Participants

Number of Participants: 60
Number of Participants with Biological Samples: 60

More info

Data Collection Event

CAMICCov - Immunosuppressed - Enrollment

Blood samples was collected. Information about demographic, medical history, medication, COVID-19 (length of hospitalization, residual symptoms, etc.) and vaccination (company, dates of the dose, etc.) was collected.

More info

Collected Dataset / CAMICCov_Immunosuppressed_Enrollment

CAMICCov_Immunosuppressed_Enrollment

Population

CAMICCov - Immunosuppressed

Data Collection Event

CAMICCov - Immunosuppressed - Enrollment

Files

Variables Classifications